Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis

Open Access

Peer-reviewed

Research Article

Min Lu,

Affiliations Department of Medical Oncology, Duke University Medical Center, Durham, North Carolina, United States of America, Center for Genomics and Computational Biology, Duke University, Durham, North Carolina, United States of America
⨯
Amelia S. Zessin,

Affiliation Department of Medical Oncology, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
Wayne Glover,

Affiliations Department of Medical Oncology, Duke University Medical Center, Durham, North Carolina, United States of America, Center for Genomics and Computational Biology, Duke University, Durham, North Carolina, United States of America
⨯
David S. Hsu

* E-mail: shiaowen.hsu@duke.edu

Affiliations Department of Medical Oncology, Duke University Medical Center, Durham, North Carolina, United States of America, Center for Genomics and Computational Biology, Duke University, Durham, North Carolina, United States of America

http://orcid.org/0000-0002-8149-7180

⨯

Reader Comments (0)

Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Hepatic resection
Is the Subject Area "Hepatic resection" applicable to this article?

Thanks for your feedback.
Colon
Is the Subject Area "Colon" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
HT29 cells
Is the Subject Area "HT29 cells" applicable to this article?

Thanks for your feedback.
Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.